These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance. Pappas KD; Gouva CD; Katopodis KP; Nikolopoulos PM; Korantzopoulos PG; Michalis LK; Goudevenos JA; Siamopoulos KC Cardiovasc Drugs Ther; 2008 Feb; 22(1):37-44. PubMed ID: 18095148 [TBL] [Abstract][Full Text] [Related]
23. Anemia of chronic renal failure: treatment with erythropoietin. Navarro M; Alonso A; Avilla JM; Espinosa L Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893 [TBL] [Abstract][Full Text] [Related]
24. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure. Morris KP; Skinner JR; Hunter S; Coulthard MG Arch Dis Child; 1993 May; 68(5):644-8. PubMed ID: 8323333 [TBL] [Abstract][Full Text] [Related]
25. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507 [TBL] [Abstract][Full Text] [Related]
26. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]
27. [The effect of blood pressure changes during hemodialysis on left ventricular systolic function]. Kaźmierczak M; Grajek S; Kaźmierczak E; Minczykowski A; Czarnecki R; Siminiak T Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):54-7. PubMed ID: 8361888 [TBL] [Abstract][Full Text] [Related]
28. Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency. Kumpuris AG; Quinones MA; Waggoner AD; Kanon DJ; Nelson JG; Miller RR Am J Cardiol; 1982 Apr; 49(5):1091-100. PubMed ID: 6461239 [TBL] [Abstract][Full Text] [Related]
29. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy. Wizemann V; Schäfer R; Kramer W Nephron; 1993; 64(2):202-6. PubMed ID: 8321352 [TBL] [Abstract][Full Text] [Related]
30. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial. Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974 [TBL] [Abstract][Full Text] [Related]
31. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487 [TBL] [Abstract][Full Text] [Related]
32. [Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency]. Jiang JP; Hou FF; Gao LZ; Pan YB; Yang NS; Chen W; Shu GY; Chen YM; Chen J; Peng WH; Wu JP; Yang ZM Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):25-9. PubMed ID: 15769393 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular function in a chronic peritoneal dialysis pediatric population on recombinant human erythropoietin treatment. Bassi S; Montini G; Edefonti A; Perfumo F; Cattarelli D; Piaggio G; Fesslova V; Zacchello G; Bove S Perit Dial Int; 1993; 13 Suppl 2():S267-9. PubMed ID: 8399585 [TBL] [Abstract][Full Text] [Related]
34. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Peteiro J; Alvarez N; Calviño R; Penas M; Ribera F; Castro Beiras A Cardiology; 1994; 85(5):273-83. PubMed ID: 7850816 [TBL] [Abstract][Full Text] [Related]
35. Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients. Sikole A; Polenakovic M; Spirovska V; Polenakovic B; Masin G Artif Organs; 1993 Dec; 17(12):977-84. PubMed ID: 8110072 [TBL] [Abstract][Full Text] [Related]
36. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients. Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178 [TBL] [Abstract][Full Text] [Related]
37. [Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin]. Rasić S; Kulenović I; Zulić I; Huskić J; Avdagić N; Babić N; Uncanin S; Haracić A Med Arh; 2004; 58(2):109-12. PubMed ID: 15202319 [TBL] [Abstract][Full Text] [Related]
38. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Carlini R; Obialo CI; Rothstein M Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228 [TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Lemmilä S; Saha H; Virtanen V; Ala-Houhala I; Pasternack A Am J Nephrol; 1998; 18(5):404-10. PubMed ID: 9730564 [TBL] [Abstract][Full Text] [Related]
40. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]